WisBusiness: UW-Madison researchers study psilocybin-based drug by Tryp Therapeutics
Two UW-Madison researchers will be conducting a clinical study on a psilocybin-based drug being developed by a Canadian pharmaceutical company. Psilocybin is the psychoactive component of so-called "magic mushrooms," which scientists around the world are studying as a potential method for treating mental health issues...